Barbados vs Tonga: Cause of death, by non-communicable diseases, ages 5-14
Barbados
38.8%
in 2021
Tonga
38.5%
in 2021
Barbados rank
86th
Tonga rank
88th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Barbados
- Tonga
How they compare
Barbados currently reports 38.8% against 38.5% in Tonga, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Barbados ahead.
Barbados ranks 86th and Tonga ranks 88th of 185 countries.
Barbados has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Barbados | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.8% | 33.0% | 7.7% | Barbados |
| 2010s | 39.9% | 36.8% | 3.1% | Barbados |
| 2020s | 40.8% | 38.3% | 2.5% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Barbados or Tonga?
- Barbados, at 38.8% against 38.5% in Tonga as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Barbados and Tonga?
- 0.3%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Tonga?
- 6 years are reported by both, from 2000 to 2021.
- How do Barbados and Tonga rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Barbados ranks 86th and Tonga ranks 88th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.